Granules India is Pharmaceuticals in India that focus on Granules India Ltd business. Founded in 1984. They cover business area such as Granules India Ltd, active pharmaceutical ingredient, pharmaceutical formulation intermediate, finished dosage, its business, three area, core molecule, Paracetamol, Ibuprofen, Metformin, Guaifenesin, Methocarbamol, api, its primary geographic market, North America, Latin America, Europe, Rest, World.
1984
( 42 years old in 2026 )
Granules India Ltd
-
2nd Floor, 3rd Block
My Home Hub, Madhapur
Hyderabad, Telengana 500081
India
Private
Granules India Ltdactive pharmaceutical ingredientpharmaceutical formulation intermediatefinished dosageits businessthree areacore moleculeParacetamolIbuprofenMetforminGuaifenesinMethocarbamolapiits primary geographic marketNorth AmericaLatin AmericaEuropeRestWorld
* We use standard office opening hours in near Granules India's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Granules India is Pharmaceuticals business from India that founded in 1984 (42 years old in 2026), Granules India business is focusing on Granules India Ltd.
Granules India headquarter office and corporate office address is located in 2nd Floor, 3rd Block My Home Hub, Madhapur Hyderabad, Telengana 500081 India.
Granules India was founded in India.
In 2026, Granules India is currently focus on Granules India Ltd sector.
Above is snippet of Google Trends for "Granules India Ltd" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Granules India, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
